Bonfix

Minimally Invasive Hallux Valgus Correction

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in September 2009 by Dror Robinson, Bonfix operates with 1–10 employees. The company secured its seed funding round in March 2023 from Docor International Management to advance its medical device for hallux valgus correction.

Business overview

Bonfix is a Health Tech & Life Sciences company focused on developing a minimally invasive device for the correction of hallux valgus, commonly known as bunions. The company aims to replace traditional osteotomy procedures with an ambulatory surgical method that minimizes functional limitations for patients. Bonfix operates within the Medical Devices sector, specifically targeting Medical Treatment & Therapeutics, and serves the Healthcare market, particularly providers.

Company Intelligence Q&A

What is Bonfix's core product?
Bonfix is developing a minimally invasive device designed for the correction of hallux valgus, or bunions, aiming to offer an alternative to traditional osteotomy procedures.
When was Bonfix founded?
Bonfix was founded in September 2009.
Who is the founder of Bonfix?
Dror Robinson is the founder of Bonfix.
What is the primary sector Bonfix operates in?
Bonfix operates primarily in the Health Tech & Life Sciences sector, with a focus on Medical Devices.
When did Bonfix secure its most recent funding?
In March 2023, Bonfix secured a seed funding round from Docor International Management.